FIELD: chemistry.
SUBSTANCE: invention relates to an amine compound of formula (I), pharmaceutically acceptable addition salts, hydrates or solvates thereof, having immunodepressive effect , where R - H or P(=O)(OH)2; X - O or S; Y denotes -CH2CH2- or -CH=CH-; Z denotes C1-5-alkylene, C2-5-alkenylene or C2-5-alkynylene; R1 denotes CF3, R2 denotes C1-4-alkyl, substituted with OH or halogen; R3 and R4 independently denotes H < or C1-4-alkyl; A denotes optionally substituted C6-10-aryl, heteroaryl containing 5-10 ring atoms, where 1 or 2 atoms are selected from N, O and S, C3-7-cycloalkyl optionally condensed with optionally substituted benzene, or heterocycloalkyl containing 5-7 ring atoms, where 1 or 2 atoms are selected from N and O, where said substitutes are selected from C1-4-alkylthio, C1-4-alkylsulphanyl, C1-4-alkylsulphonyl, C2-5-alkylcarbonyl, halogen, cyano, nitro, C3-7-cycloalkyl, C6-10-aryl, C7-14-aralkyloxy, C6-10-aryloxy, optionally substituted with oxo or halogen, C2-3-alkyleneoxy, C3-4-alkylene or C1-2-alkylenedioxy, optionally substituted with halogen C1-4-alkyl or C1-4-alkoxy.
EFFECT: novel compound which is effective in reducing the level of lymphocytes in peripheral blood, suppresses tissue breakdown and exhibiting less side effects, such as bradycardia, is disclosed.
20 cl, 237 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
AMINE COMPOUND AND ITS APPLICATION IN MEDICINAL PURPOSES | 2006 |
|
RU2433117C2 |
NEW PHARMACEUTICAL COMPOSITIONS FOR SEXUAL DISORDERS | 2005 |
|
RU2445095C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
COMPOSITIONS, BASED ON 2-AMINO-1,3-RPOPANEDIOL COMPOUNDS | 2010 |
|
RU2468793C2 |
MODULATORS OF RECEPTOR S1P FOR TREATMENT OF MULTIPLE SCLEROSIS | 2007 |
|
RU2569732C9 |
USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
AGENTS AGAINST FEEBLE-MINDEDNESS COMPRISING DERIVATIVES OF 2-ARYL-8-OXODIHYDROPURINE AS ACTIVE COMPONENT | 2001 |
|
RU2277096C2 |
DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS | 2003 |
|
RU2293078C2 |
Authors
Dates
2012-06-20—Published
2008-06-13—Filed